ZDHHC9 regulates lipid metabolic reprogramming by mediating palmitoylation of ACSL3 to promote Cetuximab resistance in Colorectal Cancer.

Song K, Ge Z, Lin Y, Xie Z, Wang T, Hao J

Open source

DOI
10.1016/j.yexcr.2026.115179
Published
2026 Sep 25
Container
Experimental cell research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.yexcr.2026.115179,
  title = {ZDHHC9 regulates lipid metabolic reprogramming by mediating palmitoylation of ACSL3 to promote Cetuximab resistance in Colorectal Cancer.},
  author = {Song K and Ge Z and Lin Y and Xie Z and Wang T and Hao J},
  year = {2026},
  journal = {Experimental cell research},
  doi = {10.1016/j.yexcr.2026.115179},
  url = {https://doi.org/10.1016/j.yexcr.2026.115179}
}

RIS

TY  - JOUR
TI  - ZDHHC9 regulates lipid metabolic reprogramming by mediating palmitoylation of ACSL3 to promote Cetuximab resistance in Colorectal Cancer.
AU  - Song K
AU  - Ge Z
AU  - Lin Y
AU  - Xie Z
AU  - Wang T
AU  - Hao J
PY  - 2026
JO  - Experimental cell research
DO  - 10.1016/j.yexcr.2026.115179
UR  - https://doi.org/10.1016/j.yexcr.2026.115179
ER  - 

APA

K, S., Z, G., Y, L., Z, X., T, W., & J, H. (2026). ZDHHC9 regulates lipid metabolic reprogramming by mediating palmitoylation of ACSL3 to promote Cetuximab resistance in Colorectal Cancer.. Experimental cell research. https://doi.org/10.1016/j.yexcr.2026.115179

Source records